Integration of Endogenous Opioid System Research in the Interprofessional Diagnosis and Treatment of Obesity and Eating Disorders

Overview

Journal Adv Neurobiol

Publisher Springer

Date 2024 Jun 14

PMID 38874732

Authors

Marcela Rodriguez Flores

Sylvana Stephano Zuniga

Affiliations

Soon will be listed here.

Abstract

This third and final chapter in our trilogy introduces the clinical distinctions and phenotypical similarities between obesity and eating disorders. Research elaborating on the shared neurobiological substrates for obesity and eating disorders is discussed. We present an interprofessional model of treatment for both disordered eating and for obesity. Additionally, this chapter establishes the translational importance of research connecting endogenous opioid activity with both obesity and eating disorders, with an emphasis on clinical interventions. We conclude with a discussion of future directions for research.

Citing Articles

Association of Gene Variants with Changes in Body Weight and Psychometric Indicators in Patients with Eating Disorders.

Gonzalez-Rodriguez L, Gonzalez L, Garcia-Herraiz A, Mota-Zamorano S, Flores I, Gervasini G J Clin Med. 2024; 13(17).

PMID: 39274402 PMC: 11396092. DOI: 10.3390/jcm13175189.

References

Aigner M, Treasure J, Kaye W, Kasper S . World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry. 2011; 12(6):400-43. DOI: 10.3109/15622975.2011.602720. View

Andries A, Frystyk J, Flyvbjerg A, Stoving R . Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial. Int J Eat Disord. 2013; 47(1):18-23. DOI: 10.1002/eat.22173. View

Apfelbaum M, Mandenoff A . Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet. Pharmacol Biochem Behav. 1981; 15(1):89-91. DOI: 10.1016/0091-3057(81)90344-0. View

Arnold M, Pandeya N, Byrnes G, Renehan P, Stevens G, Ezzati P . Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2014; 16(1):36-46. PMC: 4314462. DOI: 10.1016/S1470-2045(14)71123-4. View

Aronne L, Wadden T, Peterson C, Winslow D, Odeh S, Gadde K . Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults. Obesity (Silver Spring). 2013; 21(11):2163-71. DOI: 10.1002/oby.20584. View

Behary P, Miras A . Food preferences and underlying mechanisms after bariatric surgery. Proc Nutr Soc. 2015; 74(4):419-25. DOI: 10.1017/S0029665115002074. View

Blackburn A, Hajnal A, Leggio L . The gut in the brain: the effects of bariatric surgery on alcohol consumption. Addict Biol. 2016; 22(6):1540-1553. PMC: 5332539. DOI: 10.1111/adb.12436. View

Bluher M . Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019; 15(5):288-298. DOI: 10.1038/s41574-019-0176-8. View

Bodnar R . Endogenous opioid modulation of food intake and body weight: Implications for opioid influences upon motivation and addiction. Peptides. 2019; 116:42-62. DOI: 10.1016/j.peptides.2019.04.008. View

10.

Busetto L, Dicker D, Azran C, Batterham R, Farpour-Lambert N, Fried M . Obesity Management Task Force of the European Association for the Study of Obesity Released "Practical Recommendations for the Post-Bariatric Surgery Medical Management". Obes Surg. 2018; 28(7):2117-2121. DOI: 10.1007/s11695-018-3283-z. View

11.

Chiappetta S, Stier C, Squillante S, Theodoridou S, Weiner R . The importance of the Edmonton Obesity Staging System in predicting postoperative outcome and 30-day mortality after metabolic surgery. Surg Obes Relat Dis. 2016; 12(10):1847-1855. DOI: 10.1016/j.soard.2016.02.042. View

12.

Cota D, Tschop M, Horvath T, Levine A . Cannabinoids, opioids and eating behavior: the molecular face of hedonism?. Brain Res Rev. 2005; 51(1):85-107. DOI: 10.1016/j.brainresrev.2005.10.004. View

13.

Czyzyk T, Nogueiras R, Lockwood J, McKinzie J, Coskun T, Pintar J . kappa-Opioid receptors control the metabolic response to a high-energy diet in mice. FASEB J. 2009; 24(4):1151-9. PMC: 2845433. DOI: 10.1096/fj.09-143610. View

14.

Daniels S, Pratt M, Zhou Y, Leri F . Effect of steady-state methadone on high fructose corn syrup consumption in rats. J Psychopharmacol. 2017; 32(2):215-222. DOI: 10.1177/0269881117742116. View

15.

Drew B, Dixon A, Dixon J . Obesity management: update on orlistat. Vasc Health Risk Manag. 2008; 3(6):817-21. PMC: 2350121. View

16.

Dunn J, Cowan R, Volkow N, Feurer I, Li R, Williams D . Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings. Brain Res. 2010; 1350:123-30. PMC: 2926260. DOI: 10.1016/j.brainres.2010.03.064. View

17.

Eikemo M, Loseth G, Johnstone T, Gjerstad J, Willoch F, Leknes S . Sweet taste pleasantness is modulated by morphine and naltrexone. Psychopharmacology (Berl). 2016; 233(21-22):3711-3723. DOI: 10.1007/s00213-016-4403-x. View

18.

Farr O, Sofopoulos M, Tsoukas M, Dincer F, Thakkar B, Sahin-Efe A . GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised,.... Diabetologia. 2016; 59(5):954-65. PMC: 4826792. DOI: 10.1007/s00125-016-3874-y. View

19.

Fayh A, Lopes A, da Silva A, Reischak-Oliveira A, Friedman R . Effects of 5 % weight loss through diet or diet plus exercise on cardiovascular parameters of obese: a randomized clinical trial. Eur J Nutr. 2012; 52(5):1443-50. DOI: 10.1007/s00394-012-0450-1. View

20.

Fried M, Yumuk V, Oppert J, Scopinaro N, Torres A, Weiner R . Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2013; 24(1):42-55. DOI: 10.1007/s11695-013-1079-8. View